|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07D 413/14 | (2006.01) |
| C07D 471/04 | (2006.01) | ||
| A61K 31/422 | (2006.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 3529248 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17790813.4 |
| Date of filing the European patent application | 2017-10-18 | |
| (97) | Date of publication of the European application | 2019-08-28 |
| (45) | Date of publication and mention of the grant of the patent | 2020-08-19 |
| (46) | Date of publication of the claims translation | 2020-10-26 |
| (86) | Number | PCT/GB2017/053152 |
| Date | 2017-10-18 |
| (87) | Number | WO 2018/073586 |
| Date | 2018-04-26 |
| (30) | Number | Date | Country code |
| 201617630 | 2016-10-18 | GB |
| (72) |
PEGG, Neil Anthony, GB
ONIONS, Stuart Thomas, GB
TADDEI, David Michel Adrien, GB
SHANNON, Jonathan, GB
PAOLETTA, Silvia, GB
BROWN, Richard James, GB
SMYTH, Don, GB
HARBOTTLE, Gareth, GB
|
| (73) |
CellCentric Ltd,
Chesterford Research Park Little Chesterford, Cambridge, Cambridgeshire CB10 1XL,
GB
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Farmaciniai junginiai |
| PHARMACEUTICAL COMPOUNDS |
| Payment date | Validity (years) | Amount | |
| 2025-09-19 | 9 | 208.00 EUR |
| 2026-10-18 |